Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Eigenbrot

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Mabs|June 19, 2013
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgGXiangdan Wang, Valerie Quarmby, Carl Ng, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2019
Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket groupGregory L Hamilton, Huifen Chen, Gauri Deshmukh, et al.
Nature Structural & Molecular Biology|August 22, 2017
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonistsYingnan Zhang, Mark Ultsch, Nicholas J Skelton, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2015
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinaseEmily J Hanan, Matt Baumgardner, Marian C Bryan, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitorsSharada Labadie, Kathy Barrett, Wade S Blair, et al.
The Journal of Biological Chemistry|January 6, 2005
A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivoAlan G Olivero, Charles Eigenbrot, Richard Goldsmith, et al.
Journal of Molecular Biology|March 6, 2013
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodiesHomer Pantua, Jingyu Diao, Mark Ultsch, et al.
Nature Communications|December 23, 2020
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hingeHenry R Maun, Rajesh Vij, Benjamin T Walters, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target ActivityJames J Crawford, Wendy Lee, Adam R Johnson, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Mabs|June 19, 2013
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgGXiangdan Wang, Valerie Quarmby, Carl Ng, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2019
Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket groupGregory L Hamilton, Huifen Chen, Gauri Deshmukh, et al.
Nature Structural & Molecular Biology|August 22, 2017
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonistsYingnan Zhang, Mark Ultsch, Nicholas J Skelton, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2015
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinaseEmily J Hanan, Matt Baumgardner, Marian C Bryan, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitorsSharada Labadie, Kathy Barrett, Wade S Blair, et al.
The Journal of Biological Chemistry|January 6, 2005
A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivoAlan G Olivero, Charles Eigenbrot, Richard Goldsmith, et al.
Journal of Molecular Biology|March 6, 2013
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodiesHomer Pantua, Jingyu Diao, Mark Ultsch, et al.
Nature Communications|December 23, 2020
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hingeHenry R Maun, Rajesh Vij, Benjamin T Walters, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target ActivityJames J Crawford, Wendy Lee, Adam R Johnson, et al.
Pageof 11